Group items tagged

The General Pharmaceutical Council (GPhC) has announced plans to update the pharmacy inspection process by adopting a more targeted and flexible approach. The GPhC inspects registered pharmacies in Great Britain to ensure they meet required standards, assuring patients and the public of safe, effective care. During its Council meeting today (12), the pharmacy regulator outlined plans to improve its inspection approach, including the introduction of shorter, more focused inspections alongside the existing full inspections, to increase efficiency and enable more inspection activity. Inspectors can switch to a full inspection if they believe it is necessary or beneficial. Pharmacies being inspected for the first time will automatically undergo a full inspection. In addition to focused and full inspections, other types, such as re-inspections, intelligence-led inspections, and themed inspections, will also continue.

Essential Pharma, an international speciality pharma group, has procured an establishment and manufacturing licences in Switzerland and Malta. Following a successful inspection by Swissmedic, the company has been granted an establishment licence in Switzerland, which will allow the company to significantly enhance its supply chain efficiency for a wide range of important medicinal products. It will apply to transactions for both finished and unfinished pharmaceuticals, allowing importing, exporting, wholesaling and trading abroad. Essential Pharma has also received a manufacturing and importation authorisation (MIA) in Malta, following a successful Good Manufacturing Practice (GMP) inspection by the Malta Medicines Authority. The MIA will allow the company to import medicinal products into the European Union where manufacturing has taken place in a third country. This will allow greater flexibility in how the business manages the flow of medicines across its territories. These approvals strengthen the company's geographical expansion, improve its operational efficiencies, and enhance its offering as a global business partner. They will also provide new strategic opportunities for the company and will play a fundamental role in driving value creation through functional improvements to scale and productivity.